StonvexLoading…
StonvexStonvexStonvexCore line items from NVST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.72B | $2.51B | $2.57B | $2.57B |
Operating Income | $216.10M | $-1.04B | $31.50M | $319.20M |
Net Income | $47.00M | $-1.12B | $-100.20M | $243.10M |
EPS (Diluted) | $0.28 | $-6.50 | $-0.60 | $1.37 |
Total Assets | $5.68B | $5.35B | $6.61B | $6.59B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.21B | $1.07B | $940.00M | $606.90M |
Free Cash Flow OCF − CapEx | $230.40M | $302.70M | $217.50M | $107.00M |
Shares Outstanding | 163.80M | 172.20M | 171.50M | 163.20M |